Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Patent Application No. 19/253,088, titled ...
Le Lézard

Plaintiffs Win $22.5M Verdict in Class-Action Lawsuit Against Toronto Plastic Surgeon

Years of legal battles have culminated in a decisive judgment against a well-known Toronto plastic surgeon, Dr. Martin Jugenburg. The ruling follows a comprehensive five-week common issues trial that ...

Nomura Small Cap Core Fund Q1 2026 Commentary

For the first quarter of 2026, the Nomura Small Cap Core Fund Institutional shares underperformed the Russell 2000 Index, ...

Discover 3 Stocks That May Be Trading Below Their Estimated Value

The United States market has shown robust performance with a 2.5% increase over the last week and a remarkable 26% rise in the past year, while earnings are projected to grow by 17% annually. In this ...
Fierce Biotech

FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote

The FDA has delayed a decision on the approval of AstraZeneca’s camizestrant, deferring its ruling to review analyses filed ...